{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:11:52Z","timestamp":1794377512680,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience and Biotechnology","doi-asserted-by":"publisher","award":["KGM9942112"],"award-info":[{"award-number":["KGM9942112"]}],"id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2018M3A9H4055203"],"award-info":[{"award-number":["2018M3A9H4055203"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Highly contagious respiratory diseases caused by viral infections are a constantly emerging threat, particularly the elderly with the higher risk of developing serious complications. Vaccines are the best strategy for protection against influenza-related diseases. However, the elderly has lower vaccine efficacy than young population\u00a0and the age-driven decline of the influenza vaccine efficacy remains unresolved.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This study investigates the effect of an adjuvant, poly-\u03b3-glutamic acid and alum (PGA\/Alum) on vaccine efficacy in aged mice (18-months) and its mechanism is investigated using ovalbumin as a model antigen and a commercial pandemic H1N1 (pH1N1)\u00a0flu vaccine. Antigen trafficking, dendritic cell (DC) activation, and the DC-mediated T cell activation were analyzed via in vivo imaging and flow cytometry. Antigen-specific humoral and cellular immune responses were evaluated in sera and splenocytes from the vaccinated mice. Also, we analyzed gene expression profiles of splenocytes from the vaccinated mice via single-cell transcriptome sequencing and evaluated the protective efficacy against pH1N1 virus challenge.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Aged mice had lower antigen trafficking and DC activation than younger mice (6-weeks), which was ameliorated by PGA\/Alum with increased antigen uptake and DC activation leading to improved antigen-specific IFN-\u03b3<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T lymphocyte frequencies higher in the vaccinated aged mice, to a similar extent as PGA\/Alum adjuvanted vaccine-immunized young mice. The results of single-cell transcriptome sequencing display that PGA\/Alum also reduced the proportion of age-associated CD8<jats:sup>+<\/jats:sup> T cell subsets and gene levels of inhibitory regulators in CD8<jats:sup>+<\/jats:sup> T cells, which may play a role in the recovery of CD8<jats:sup>+<\/jats:sup> T cell activation. Finally, PGA\/Alum adjuvanted pH1N1 vaccine-immunized aged mice were completely protected (100% survival) compared to aged mice immunized with vaccine only (0% survival) after pH1N1 virus challenge, akin to the efficacy of the vaccinated young mice (100% survival).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PGA\/Alum adjuvanted pH1N1 vaccine-immunized aged mice showed a significant increase in vaccine efficacy compared to aged mice administered with vaccine only. The enhanced vaccine efficacy by PGA\/Alum is associated with significant increases of\u00a0activation of DCs and effector CD8<jats:sup>+<\/jats:sup> T cells and a decrease in age-associated CD8<jats:sup>+<\/jats:sup> T cell proportion of splenocytes. Collectively, PGA\/Alum adjuvanted flu vaccine may be a promising vaccine candidate for the elderly.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12979-022-00282-z","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T05:03:43Z","timestamp":1653282223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Poly-\u03b3-glutamic acid\/Alum adjuvanted pH1N1 vaccine-immunized aged mice exhibit a significant increase in vaccine efficacy with a decrease in age-associated CD8+ T cell proportion in splenocytes"],"prefix":"10.1186","volume":"19","author":[{"given":"Jihyun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaemoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaewon","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haryoung","family":"Poo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"282_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/859090","volume":"2014","author":"N Nikitin","year":"2014","unstructured":"Nikitin N, Petrova E, Trifonova E, Karpova O. Influenza virus aerosols in the air and their infectiousness. Adv Virol. 2014;2014: 859090. https:\/\/doi.org\/10.1155\/2014\/859090.","journal-title":"Adv Virol"},{"key":"282_CR2","doi-asserted-by":"publisher","unstructured":"Whitley Richard\u00a0J, Monto Arnold\u00a0S. Prevention and Treatment of Influenza in High\u2010Risk Groups: Children, Pregnant Women, Immunocompromised Hosts, and Nursing Home Residents. The Journal of Infectious Diseases. 2006;194(Supplement_2):S133-S8. https:\/\/doi.org\/10.1086\/507548","DOI":"10.1086\/507548"},{"issue":"14\u201315","key":"282_CR3","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.micinf.2010.08.009","volume":"12","author":"J Leng","year":"2010","unstructured":"Leng J, Goldstein DR. Impact of aging on viral infections. Microbes Infect. 2010;12(14\u201315):1120\u20134. https:\/\/doi.org\/10.1016\/j.micinf.2010.08.009.","journal-title":"Microbes Infect"},{"issue":"10","key":"282_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/s1473-3099(07)70236-0","volume":"7","author":"L Simonsen","year":"2007","unstructured":"Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7(10):658\u201366. https:\/\/doi.org\/10.1016\/s1473-3099(07)70236-0.","journal-title":"Lancet Infect Dis"},{"key":"282_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.smim.2018.10.010","volume":"40","author":"A Ciabattini","year":"2018","unstructured":"Ciabattini A, Nardini C, Santoro F, Garagnani P, Franceschi C, Medaglini D. Vaccination in the elderly: The challenge of immune changes with aging. Semin Immunol. 2018;40:83\u201394. https:\/\/doi.org\/10.1016\/j.smim.2018.10.010.","journal-title":"Semin Immunol"},{"issue":"282","key":"282_CR6","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","volume":"2015","author":"AK Simon","year":"1821","unstructured":"Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 1821;2015(282):20143085. https:\/\/doi.org\/10.1098\/rspb.2014.3085.","journal-title":"Proc Biol Sci"},{"key":"282_CR7","doi-asserted-by":"publisher","unstructured":"Lidzbarsky G, Gutman D, Shekhidem HA, Sharvit L, Atzmon G. Genomic Instabilities, Cellular Senescence, and Aging: In Vitro, In Vivo and Aging-Like Human Syndromes. Front Med (Lausanne). 2018;5:104. https:\/\/doi.org\/10.3389\/fmed.2018.00104","DOI":"10.3389\/fmed.2018.00104"},{"issue":"1","key":"282_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","volume":"12","author":"MT Osterholm","year":"2012","unstructured":"Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36\u201344. https:\/\/doi.org\/10.1016\/S1473-3099(11)70295-X.","journal-title":"Lancet Infect Dis"},{"key":"282_CR9","doi-asserted-by":"crossref","unstructured":"Steinman RM, Hemmi H. Dendritic Cells: Translating Innate to Adaptive Immunity. In: Pulendran B, Ahmed R, editors. From Innate Immunity to Immunological Memory. Berlin, Heidelberg: Springer Berlin Heidelberg; 2006. p. 17\u201358.","DOI":"10.1007\/3-540-32636-7_2"},{"issue":"11","key":"282_CR10","doi-asserted-by":"publisher","first-page":"6912","DOI":"10.4049\/jimmunol.178.11.6912","volume":"178","author":"A Agrawal","year":"2007","unstructured":"Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol. 2007;178(11):6912\u201322. https:\/\/doi.org\/10.4049\/jimmunol.178.11.6912.","journal-title":"J Immunol"},{"issue":"1","key":"282_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1515\/acve-2015-0003","volume":"65","author":"B Biljana","year":"2015","unstructured":"Biljana B, Zorica S-V, Jasmina D, Du\u0161ko K, Ivan P, Mirjana N-A, et al. Aging impairs endocytic capacity of splenic dendritic cells from Dark Agouti rats and alters their response to TLR4 stimulation. Acta Vet. 2015;65(1):30\u201355.","journal-title":"Acta Vet"},{"issue":"6","key":"282_CR12","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.4049\/jimmunol.1501006","volume":"195","author":"CA Chougnet","year":"2015","unstructured":"Chougnet CA, Thacker RI, Shehata HM, Hennies CM, Lehn MA, Lages CS, et al. Loss of Phagocytic and Antigen Cross-Presenting Capacity in Aging Dendritic Cells Is Associated with Mitochondrial Dysfunction. J Immunol. 2015;195(6):2624\u201332. https:\/\/doi.org\/10.4049\/jimmunol.1501006.","journal-title":"J Immunol"},{"issue":"4","key":"282_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.mad.2011.03.005","volume":"132","author":"LF Pereira","year":"2011","unstructured":"Pereira LF, de Souza AP, Borges TJ, Bonorino C. Impaired in vivo CD4+ T cell expansion and differentiation in aged mice is not solely due to T cell defects: decreased stimulation by aged dendritic cells. Mech Ageing Dev. 2011;132(4):187\u201394. https:\/\/doi.org\/10.1016\/j.mad.2011.03.005.","journal-title":"Mech Ageing Dev"},{"issue":"10","key":"282_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140672","volume":"10","author":"ER Zacca","year":"2015","unstructured":"Zacca ER, Crespo MI, Acland RP, Roselli E, Nunez NG, Maccioni M, et al. Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 Ligand. PLoS ONE. 2015;10(10): e0140672. https:\/\/doi.org\/10.1371\/journal.pone.0140672.","journal-title":"PLoS ONE"},{"issue":"5","key":"282_CR15","first-page":"595","volume":"138","author":"N Salam","year":"2013","unstructured":"Salam N, Rane S, Das R, Faulkner M, Gund R, Kandpal U, et al. T cell ageing: effects of age on development, survival & function. Indian J Med Res. 2013;138(5):595\u2013608.","journal-title":"Indian J Med Res"},{"issue":"4","key":"282_CR16","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.4049\/jimmunol.1101098","volume":"188","author":"V Decman","year":"2012","unstructured":"Decman V, Laidlaw BJ, Doering TA, Leng J, Ertl HC, Goldstein DR, et al. Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors. J Immunol. 2012;188(4):1933\u201341. https:\/\/doi.org\/10.4049\/jimmunol.1101098.","journal-title":"J Immunol"},{"issue":"5","key":"282_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1474-9726.2010.00611.x","volume":"9","author":"CS Lages","year":"2010","unstructured":"Lages CS, Lewkowich I, Sproles A, Wills-Karp M, Chougnet C. Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1\/ PD-L1 pathway. Aging Cell. 2010;9(5):785\u201398. https:\/\/doi.org\/10.1111\/j.1474-9726.2010.00611.x.","journal-title":"Aging Cell"},{"key":"282_CR18","doi-asserted-by":"publisher","unstructured":"Elyahu Y, Hekselman I, Eizenberg-Magar I, Berner O, Strominger I, Schiller M, et al. Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Science Advances. 2019;5(8):eaaw8330. https:\/\/doi.org\/10.1126\/sciadv.aaw8330","DOI":"10.1126\/sciadv.aaw8330"},{"issue":"2","key":"282_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/acel.12435","volume":"15","author":"K-A Lee","year":"2016","unstructured":"Lee K-A, Shin K-S, Kim G-Y, Song YC, Bae E-A, Kim I-K, et al. Characterization of age-associated exhausted CD8+ T cells defined by increased expression of Tim-3 and PD-1. Aging Cell. 2016;15(2):291\u2013300. https:\/\/doi.org\/10.1111\/acel.12435.","journal-title":"Aging Cell"},{"issue":"2","key":"282_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s12276-021-00568-0","volume":"53","author":"W Seo","year":"2021","unstructured":"Seo W, Jerin C, Nishikawa H. Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion. Exp Mol Med. 2021;53(2):202\u20139. https:\/\/doi.org\/10.1038\/s12276-021-00568-0.","journal-title":"Exp Mol Med"},{"issue":"21","key":"282_CR21","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.vaccine.2017.03.092","volume":"35","author":"K Wilkinson","year":"2017","unstructured":"Wilkinson K, Wei Y, Szwajcer A, Rabbani R, Zarychanski R, Abou-Setta AM, et al. Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis. Vaccine. 2017;35(21):2775\u201380. https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.092.","journal-title":"Vaccine"},{"issue":"4","key":"282_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.vaccine.2016.12.011","volume":"35","author":"A Domnich","year":"2017","unstructured":"Domnich A, Arata L, Amicizia D, Puig-Barbera J, Gasparini R, Panatto D. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis. Vaccine. 2017;35(4):513\u201320. https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.011.","journal-title":"Vaccine"},{"issue":"1","key":"282_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11357-021-00323-3","volume":"43","author":"J Connors","year":"2021","unstructured":"Connors J, Bell MR, Marcy J, Kutzler M, Haddad EK. The impact of immuno-aging on SARS-CoV-2 vaccine development. Geroscience. 2021;43(1):31\u201351. https:\/\/doi.org\/10.1007\/s11357-021-00323-3.","journal-title":"Geroscience"},{"key":"282_CR24","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3389\/fimmu.2019.01604","volume":"10","author":"QT Nguyen","year":"2019","unstructured":"Nguyen QT, Kwak C, Lee WS, Kim J, Jeong J, Sung MH, et al. Poly-gamma-Glutamic Acid Complexed With Alum Induces Cross-Protective Immunity of Pandemic H1N1 Vaccine. Front Immunol. 2019;10:1604. https:\/\/doi.org\/10.3389\/fimmu.2019.01604.","journal-title":"Front Immunol"},{"issue":"6","key":"282_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/tcr.20061","volume":"5","author":"MH Sung","year":"2005","unstructured":"Sung MH, Park C, Kim CJ, Poo H, Soda K, Ashiuchi M. Natural and edible biopolymer poly-gamma-glutamic acid: synthesis, production, and applications. Chem Rec. 2005;5(6):352\u201366. https:\/\/doi.org\/10.1002\/tcr.20061.","journal-title":"Chem Rec"},{"key":"282_CR26","doi-asserted-by":"publisher","unstructured":"Di Pasquale A, Preiss S, Tavares Da Silva F, Garcon N. Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines (Basel). 2015;3(2):320\u201343. https:\/\/doi.org\/10.3390\/vaccines3020320","DOI":"10.3390\/vaccines3020320"},{"issue":"2","key":"282_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.exger.2009.11.005","volume":"45","author":"CP Wong","year":"2010","unstructured":"Wong CP, Magnusson KR, Ho E. Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production. Exp Gerontol. 2010;45(2):163\u20139. https:\/\/doi.org\/10.1016\/j.exger.2009.11.005.","journal-title":"Exp Gerontol"},{"key":"282_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jcv.2019.08.009","volume":"119","author":"JM Jansen","year":"2019","unstructured":"Jansen JM, Gerlach T, Elbahesh H, Rimmelzwaan GF, Saletti G. Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. J Clin Virol. 2019;119:44\u201352. https:\/\/doi.org\/10.1016\/j.jcv.2019.08.009.","journal-title":"J Clin Virol"},{"key":"282_CR29","doi-asserted-by":"publisher","unstructured":"Mogilenko DA, Shpynov O, Andhey PS, Arthur L, Swain A, Esaulova E, et al. Comprehensive Profiling of an Aging Immune System Reveals Clonal GZMK(+) CD8(+) T Cells as Conserved Hallmark of Inflammaging. Immunity. 2021;54(1):99\u2013115 e12. https:\/\/doi.org\/10.1016\/j.immuni.2020.11.005","DOI":"10.1016\/j.immuni.2020.11.005"},{"issue":"12","key":"282_CR30","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1016\/j.celrep.2018.05.057","volume":"23","author":"KM Quinn","year":"2018","unstructured":"Quinn KM, Fox A, Harland KL, Russ BE, Li J, Nguyen THO, et al. Age-Related Decline in Primary CD8(+) T Cell Responses Is Associated with the Development of Senescence in Virtual Memory CD8(+) T Cells. Cell Rep. 2018;23(12):3512\u201324. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.057.","journal-title":"Cell Rep"},{"issue":"3","key":"282_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150425","volume":"11","author":"A Ramirez","year":"2016","unstructured":"Ramirez A, Co M, Mathew A. CpG Improves Influenza Vaccine Efficacy in Young Adult but Not Aged Mice. PLoS ONE. 2016;11(3): e0150425. https:\/\/doi.org\/10.1371\/journal.pone.0150425.","journal-title":"PLoS ONE"},{"key":"282_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fimmu.2018.00295","volume":"9","author":"SL Baldwin","year":"2018","unstructured":"Baldwin SL, Hsu FC, Van Hoeven N, Gage E, Granger B, Guderian JA, et al. Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection. Front Immunol. 2018;9:295. https:\/\/doi.org\/10.3389\/fimmu.2018.00295.","journal-title":"Front Immunol"},{"key":"282_CR33","doi-asserted-by":"crossref","unstructured":"Sambhara S, McElhaney JE. Immunosenescence and Influenza Vaccine Efficacy. In: Compans RW, Orenstein WA, editors. Vaccines for Pandemic Influenza. Berlin, Heidelberg: Springer Berlin Heidelberg; 2009. p. 413\u201329.","DOI":"10.1007\/978-3-540-92165-3_20"},{"key":"282_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.coph.2018.03.014","volume":"41","author":"B Weinberger","year":"2018","unstructured":"Weinberger B. Adjuvant strategies to improve vaccination of the elderly population. Curr Opin Pharmacol. 2018;41:34\u201341. https:\/\/doi.org\/10.1016\/j.coph.2018.03.014.","journal-title":"Curr Opin Pharmacol"},{"issue":"11","key":"282_CR35","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00262-009-0689-4","volume":"58","author":"TY Lee","year":"2009","unstructured":"Lee TY, Kim YH, Yoon SW, Choi JC, Yang JM, Kim CJ, et al. Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect. Cancer Immunol Immunother. 2009;58(11):1781\u201394. https:\/\/doi.org\/10.1007\/s00262-009-0689-4.","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"282_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003490","volume":"9","author":"M Isogawa","year":"2013","unstructured":"Isogawa M, Chung J, Murata Y, Kakimi K, Chisari FV. CD40 activation rescues antiviral CD8(+) T cells from PD-1-mediated exhaustion. PLoS Pathog. 2013;9(7): e1003490. https:\/\/doi.org\/10.1371\/journal.ppat.1003490.","journal-title":"PLoS Pathog"},{"issue":"6","key":"282_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/cmi.2016.23","volume":"14","author":"R Wang","year":"2017","unstructured":"Wang R, Xu A, Zhang X, Wu J, Freywald A, Xu J, et al. Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway. Cell Mol Immunol. 2017;14(6):529\u201345. https:\/\/doi.org\/10.1038\/cmi.2016.23.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"282_CR38","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.bbrc.2017.01.172","volume":"484","author":"A Xu","year":"2017","unstructured":"Xu A, Wang R, Freywald A, Stewart K, Tikoo S, Xu J, et al. CD40 agonist converting CTL exhaustion via the activation of the mTORC1 pathway enhances PD-1 antagonist action in rescuing exhausted CTLs in chronic infection. Biochem Biophys Res Commun. 2017;484(3):662\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2017.01.172.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"282_CR39","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/sj.cdd.4401011","volume":"9","author":"Y Zhang","year":"2002","unstructured":"Zhang Y, Wang Y, Gilmore X, Xu K, Chen M, Tebebi P, et al. Apoptosis and reduced influenza A virus specific CD8+ T cells in aging mice. Cell Death Differ. 2002;9(6):651\u201360. https:\/\/doi.org\/10.1038\/sj.cdd.4401011.","journal-title":"Cell Death Differ"},{"issue":"2","key":"282_CR40","doi-asserted-by":"publisher","first-page":"980","DOI":"10.4049\/jimmunol.182.2.980","volume":"182","author":"AC Finnefrock","year":"2009","unstructured":"Finnefrock AC, Tang A, Li F, Freed DC, Feng M, Cox KS, et al. PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination. J Immunol. 2009;182(2):980\u20137. https:\/\/doi.org\/10.4049\/jimmunol.182.2.980.","journal-title":"J Immunol"},{"issue":"5","key":"282_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41590-019-0320-6","volume":"20","author":"M Koutsakos","year":"2019","unstructured":"Koutsakos M, Illing PT, Nguyen THO, Mifsud NA, Crawford JC, Rizzetto S, et al. Human CD8(+) T cell cross-reactivity across influenza A. B and C viruses Nat Immunol. 2019;20(5):613\u201325. https:\/\/doi.org\/10.1038\/s41590-019-0320-6.","journal-title":"B and C viruses Nat Immunol"},{"issue":"4","key":"282_CR42","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","volume":"25","author":"JH Kreijtz","year":"2007","unstructured":"Kreijtz JH, Bodewes R, van Amerongen G, Kuiken T, Fouchier RA, Osterhaus AD, et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine. 2007;25(4):612\u201320. https:\/\/doi.org\/10.1016\/j.vaccine.2006.08.036.","journal-title":"Vaccine"},{"issue":"2","key":"282_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3947\/ic.2013.45.2.159","volume":"45","author":"TF Tsai","year":"2013","unstructured":"Tsai TF. Fluad(R)-MF59(R)-Adjuvanted Influenza Vaccine in Older Adults. Infect Chemother. 2013;45(2):159\u201374. https:\/\/doi.org\/10.3947\/ic.2013.45.2.159.","journal-title":"Infect Chemother"},{"key":"282_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cytogfr.2020.04.005","volume":"53","author":"M Bonafe","year":"2020","unstructured":"Bonafe M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev. 2020;53:33\u20137. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.04.005.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"282_CR45","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41577-020-0402-6","volume":"20","author":"Z Chen","year":"2020","unstructured":"Chen Z, John WE. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20(9):529\u201336. https:\/\/doi.org\/10.1038\/s41577-020-0402-6.","journal-title":"Nat Rev Immunol"}],"container-title":["Immunity &amp; Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-022-00282-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12979-022-00282-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-022-00282-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T05:03:48Z","timestamp":1653282228000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/s12979-022-00282-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1186\/s12979-022-00282-z","relation":{},"ISSN":["1742-4933"],"issn-type":[{"value":"1742-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"1 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of KRIBB (KRIBB-AEC-20042).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}